The centromedial amygdala (CeM), a subdivision of the central amygdala (CeA), is believed to be the main output station of the amygdala for fear expression. We provide evidence that the Tac2 gene, expressed by neurons specifically within the CeM, is required for modulating fear memories. Tac2 is colocalized with GAD65 and CaMKIIa but not with PKCd and Enk neurons in the CeM. Moreover, the Tac2 product, NkB, and its specific receptor, Nk3R, are also involved in the consolidation of fear memories. Increased Tac2 expression, through a stress-induced PTSD-like model, or following lentiviral CeA overexpression, are sufficient to enhance fear consolidation. This effect is blocked by the Nk3R antagonist osanetant. Concordantly, silencing of Tac2-expressing neurons in CeA with DREADDs impairs fear consolidation. Together, these studies further our understanding of the role of the Tac2 gene and CeM in fear processing and may provide approaches to intervention for fear-related disorders.
INTRODUCTION
Among learning and memory processes, fear memories are crucial in anxiety disorders such as panic disorder, phobia, and posttraumatic stress disorder (PTSD). PTSD occurs in some individuals after experiencing or witnessing extreme traumatic events. The symptoms of PTSD include re-experiencing memories of these traumatic events through intrusive thoughts, flashbacks, and nightmares (American Psychiatric Association, 2013) . PTSD is also generally accompanied by hyperarousal symptoms. Moreover, persistent highly aversive memories related to the trauma, potentially overconsolidated memories, and the inability of these memories to be extinguished are all frequent characteristics of this disorder. Specifically relevant is the memory consolidation phase following emotional learning, since it is required to stabilize the initial fear memory trace.
In order to decrease the prevalence of PTSD, it is necessary to identify biological and environmental risk and resilience markers (Norrholm and Ressler, 2009; Vermetten and Lanius, 2012) , to find early interventions after trauma exposure (Kearns et al., 2012) , and to treat the disorder when it is present and debilitating (Andero and Ressler, 2012; Hetrick et al., 2010) . Notably, understanding molecular pathways mediating the initial fear consolidation event is particularly important to target the prevention of PTSD. The only FDA-approved pharmaceutical treatments for PTSD are selective serotonin reuptake inhibitor (SSRI) antidepressants, which have met with limited results in clinical trials (Hetrick et al., 2010) . Even when antidepressants are combined with exposure-based psychotherapy, increased effectiveness has not always been demonstrated (Hetrick et al., 2010) . Thus, more effective, targeted approaches to prevention and treatment are needed to normalize the functioning of areas key to fear processes such as the amygdala, the hippocampus, or the medial prefrontal cortex (mPFC).
The tachykinins refer to two peptides encoded in rodents by the Tachykinin 1 (Tac1) and Tac2 (TAC3 in humans) genes, which are involved in neurotransmission and neuromodulation in the CNS (Beaujouan et al., 2004) . Tac1 encodes a precursor protein that produces two peptides, substance P (SP) and neurokinin A (NkA), whereas Tac2/TAC3 encodes neurokinin B (NkB). SP and NkA have been previously implicated in fear processes and PTSD (Dunlop et al., 2012) . Unfortunately, clinical trials with pharmaceutical agents targeting the Tac1 pathway have not previously shown beneficial effects in PTSD treatment (Dunlop et al., 2012) . A possible explanation for this lack of effect is that the SP and NkA receptors (Neurokinin 1 receptor [Nk1R] and Neurokinin 2 receptor [Nk2R] ) are widely expressed in the brain. So, when administering drugs that specifically target Nk1 and Nk2, they interact with multiple brain regions affecting multiple functions (Beaujouan et al., 2004) . In contrast, the expression of Tac2, NkB, and its specific receptor, Neurokinin 3 receptor (Nk3R), are relatively restricted in rodents to brain regions that regulate emotion, such as the amygdala (Beaujouan et al., 2004; Duarte et al., 2006) . Nk3R is a G protein-coupled tachykinin receptor that binds NkB with highest affinity (Gether, 2000; Khawaja and Rogers, 1996) . Nk3R couples to the pertussis toxin-insensitive G proteins Gq/G 11 , the activation of which results in the production of inositol triphosphate and diacylglycerol and the activation of protein kinase C (Khawaja and Rogers, 1996) . Additionally, it has been shown that TAC3 and Nk3R are expressed in the equivalent areas in rhesus monkeys and humans (Mileusnic et al., 1999; Nagano et al., 2006) .
Here, beginning with an unbiased discovery approach, we show that the Tac2 gene is dynamically regulated during the consolidation of conditioned fear within the central amygdala (CeA). Additionally, Nk3R activation is required for normal consolidation of fear memory formation in mice. Furthermore, increased expression of the Tac2 gene, NkB peptide, and activation of Nk3R may be involved in stress sensitization and overconsolidation of fear. In contrast, genetic silencing of Tac2-expressing neurons impairs fear consolidation. Blockade of this pathway may provide for a novel therapeutic approach for disorders with altered fear learning such as PTSD.
RESULTS

Tac2 Is Involved in Fear Learning
Using amygdala tissue punches from mice that had been sacrificed 30 min or 2 hr after auditory fear conditioning (FC) (CS, acoustic tone; US, electric footshocks; Figure S1A available online), we performed an mRNA microarray. Using average linkage hierarchical clustering, the microarray heat map shows differential gene regulation at 30 min and at 2 hr after fear learning, which is a critical period for consolidation of fear memories (Ressler et al., 2002; Figure 1A ). False discovery rate (FDR) was (B) Tac2 mRNA levels are rapidly upregulated in the amygdala during fear consolidation 30 min after fear conditioning. *p % 0.05 versus HC and 2 hr. n = 7-8 per group. (C) Tac2 upregulation occurs when the conditioned stimulus (acoustic tone) and the unconditioned stimulus (electric footshock) are paired but not when they are unpaired. *p % 0.05 versus HC and unpaired. n = 11-15 per group. Mean + SEM is shown. (D) Tac2 expression by radioactive in situ hybridization in the amygdala is restricted to the central amygdala (CeA) with highest expression in the CeM amygdala. Scale bar, 1 mm. See also Figure S1 and Tables S1 and S2. calculated with SAM 4.01 using a standard 5% cutoff criteria. The cutoff criteria was set with an FDR at the 1.3-fold level for the 2 hr after fear conditioning (FC) group, since with the more conservative 1.5-fold cutoff used in the 30 min after FC group, no genes were initially identified. The criteria followed in Tables S1  and S2 for a Yes in the column ''Specifically highly expressed in the amygdala'' is the following: (1) very high expression in the amygdala (red color, Allen Brain Atlas), and (2) no expression of the gene in the hippocampus or PFC (other key areas related to emotional learning). Moreover, from the top candidates of this microarray, the only gene that is specifically highly expressed in the amygdala and belongs to a ''druggable'' pathway with available agonists and antagonists that cross the blood-brain barrier and can be used systemically is Tac2 (see Tables S1 and S2 ; Figures S1B and S2) . Therefore, we focused on understanding and manipulating the Tac2 pathway.
Independent replication studies with additional fear-conditioned mice show that Tac2 is rapidly upregulated at 30 min after FC, returning to basal levels at 2 hr (ANOVA F 3,28 = 5.014, p % 0.01, post hoc *p % 0.05 versus home cage [HC] and 2 hr; Figure 1B ). Moreover, in an additional replication, Tac2 mRNA upregulation only occurred when the conditioned and unconditioned stimuli are paired but not when they are unpaired, suggesting that within this paradigm, Tac2-increased expression is specific to associative cued fear learning and independent of nonspecific stress and/or contextual learning (ANOVA F 2,36 = 3.93, p % 0.05, post hoc *p % 0.05 versus HC and unpaired; Figure 1C ). See Figure S3 for detailed interactions of the Tac2 gene and Nk3R.
Tac2, NkB, and Nk3R in the Amygdala Figures 1D and S1B show a radioactive in situ hybridization demonstrating that the areas where Tac2 gene is expressed are quite specific and limited within in the mouse brain: bed nucleus of the stria terminalis, hypothalamus, habenula, central amygdala (CeA), zona incerta, and medial mammillary nucleus. Tac2 is highly expressed in the CeA within the amygdala, with no expression in the basolateral amygdala (BLA) or lateral amygdala (LA) ( Figure 1D ). The highest expression of Tac2 within the CeA occurs in the medial subdivision of the central amygdaloid nucleus (CeM), whereas lower expression is observed in the centrolateral (CeL) and centrocentral (CeC) amygdala. Recently, specific cell populations within the central nucleus have received attention for distinct roles in fear learning. For example, PKCd has been suggested to be part of a microcircuit in which the CeL amygdala neurons inhibit neuronal output to the CeM during the conditioned stimulus, which drives fear expression, called CeL off units (Haubensak et al., 2010) . Moreover, around 40% of protein kinase C delta (PKCd)-expressing neurons also express Enkephalin (Enk) in the CeL (Haubensak et al., 2010) . Of note, Enk mRNA levels are increased after FC in the CeL (Petrovich et al., 2000) . Since other neuronal populations have been previously related to fear processes in the CeA, we wished to examine whether Tac2 mRNA colocalized with them, suggesting functional interactions. Using double fluorescent in situ hybridization (FISH), we show that Tac2 gene expression is mostly not colocalized with PKCd or Enk and is expressed primarily within the CeM (Figures 2A-2F ). Thus, given the lack of colocalization and regional and functional specificity of these cell populations, we have uncovered a subdivision-specific cell population that may be involved in the consolidation of fear memory. Additionally, the colocalization of Tac2 mRNA levels and the 65 kDa isoform of glutamic acid decarboxylase (GAD65) peptide in the CeM ( Figure 2G ) may provide deeper understanding of the functions of gamma-aminobutyric acid (GABA) in fear learning. CalmodulinDependent Protein Kinase II a (CaMKIIa), a well-characterized neuronal population involved in synaptic plasticity, is also colocalized with Tac2 mRNA in the CeM ( Figure 2H ). Interestingly, GAD65 and CaMKII are associated with the consolidation of fear memories in the amygdala, although little is known about the specific role of these peptides in each substructure (Bergado-Acosta et al., 2008; Lepicard et al., 2006) .
We also examined detection of the NkB peptide in amygdala cell culture, demonstrating that the peptide is highly present in both soma of neurons and dendrites ( Figure 3A ). Moreover, NkB peptide is also highly expressed in the CeA ( Figure 3B ). Interestingly, NkB is upregulated in the amygdala 2 hr after FC (Student's t test, t = À2.902, **p % 0.01 fear conditioning versus home cage; Figure 3C ). The Nk3R antagonist osanetant has already been used in humans in clinical trials for schizophrenia. Although it appears to have no beneficial effects in the treatment of schizophrenia, these studies show that it is well tolerated and safe in humans (Meltzer et al., 2004) . Here, in amygdala cell culture, osanetant inactivates the Nk3R and leads to a compensatory increase in Nk3R expression as suggested by dosedependent enhanced Nk3R mRNA levels (ANOVA F 3,5 = 10.014, p % 0.05; post hoc *p % 0.05 versus Vehicle (Veh), **p % 0.01 versus Veh; Figure 3D ).
Osanetant and Emotional Learning
The above studies suggest that osanetant may be an ideal candidate to target the Nk3R in the amygdala in vivo, and we wished to examine its effects behaviorally. Osanetant given systemically, 30 min before open-field, elevated plus maze, and the conditioning chamber elicits no changes in anxiety-like behavior, locomotor activity, or electric shock reactivity (Figure S4) . Notably, when osanetant is dosed from 30 min before auditory FC up to 1 hr after training, it does not affect fear acquisition but impairs fear memory consolidation as shown by decreased freezing in the fear expression test (Figures 4A and S4G; Student's t test, 30 min, t = 3.042; 10 min after FC, t = 2.277; 1 hr after FC, t = 2.872; *p % 0.05 versus vehicle).
Recently, the PACAP-PAC1R pathway has been associated with PTSD in humans as well as in animal models Stevens et al., 2014) . These prior data showed that expression of the ADCYAP1R1 gene (encoding the PAC1 receptor) is increased following FC. Here we found that osanetant given before FC also normalizes the levels of ADCYAP1R1 mRNA levels in the amygdala (ANOVA F 2,31 = 5.541, p % 0.01; post hoc *p % 0.05 versus Veh-FC; **p % 0.01 versus Veh-FC; Figure 4B ). These data suggest that inhibition of the Tac2/ NKB/Nk3R pathway may prevent activation of a stress-related gene pathway previously associated with PTSD. Concordantly, bilateral infusion of osanetant in the CeA also impairs fear memory consolidation, suggesting that CeA-NK3R are required for the formation for emotional memories (Student's t test; t = 2.268, *p % 0.05 versus vehicle; Figures 4C and 4D) .
We have shown in previous studies that mice exposed for 2 hr to a severe one-time stressor, immobilization to a wooden board (IMO), present long-term PTSD-like symptoms: impaired fear extinction and spatial memory and enhanced anxiety-like behaviors (Andero et al., 2011 (Andero et al., , 2013 . Additionally, IMO in rats elicits alterations of the hypothalamic-pituitary-adrenal (HPA) axis that may be similar to the process initiating PTSD in humans (Armario et al., 2008) . Notably, Tac2 mRNA levels were more robustly upregulated in IMO-treated mice than in naive mice after FC, consistent with enhanced Tac2-dependent fear processing (ANOVA F 3,53 = 6.242, p % 0.001, post hoc *p % 0.05 versus HC, **p % 0.01 versus IMO; Figure 4F ). Additionally, osanetant given systemically after FC impaired memory consolidation in IMO-treated mice, as shown by decreased freezing in the fear expression test (ANOVA repeated-measures, F 1,13 = 6.072, *p % 0.05; Figure 4G ). This suggests that Nk3R antagonism reduces enhanced fear memory consolidation in a PTSD-like model. 
Tac2 Overexpression and Blockade by Osanetant
We next developed a viral vector to overexpress the Tac2 gene in an inducible fashion within the brain, the lentivirus-Tac2 (LVTac2). We first tested its functional expression by infecting HEK293 cells with the LV-Tac2 compared to control LV-GFP lentiviruses, demonstrating that the NkB peptide was robustly expressed ( Figures 5A and 5B) . We then examined the behavioral effects of Tac2 overexpression in mice. LV-Tac2 or LV-GFP were bilaterally infused in the CeA (Figures 5C and 5D ) and 14 days later Tac2 was found to be overexpressed by 42%, as determined by mRNA levels with in situ hybridization, compared to mice that had received LV-GFP (Student's t test; t = À3.841, ***p % 0.001 versus LV-GFP; Figure 5E ). Mice infected with the LV-Tac2 or LV-GFP received systemic osanetant or vehicle immediately after FC, and then fear expression was tested 24 hr later. Specific CeATac2 overexpression elicited a significant enhancement of fear memory consolidation (ANOVA F 3,20 = 8.512, p % 0.05; post (G) Osanetant was given immediately after FC and impaired fear memory consolidation in mice that had been previously exposed to a traumatic stress as shown by reduced freezing in the fear expression test, *p % 0.05. n = 8 per group. Mean + or ± SEM is shown. Veh, vehicle; Osa, osanetant. hoc **p % 0.01 versus LV-GFP-Veh; Figure 5H, right) . Interestingly, we found that Tac2 overexpression in the CeA did not induce changes in anxiety-like behavior or fear acquisition ( Figures 5G and 5H ). Replicating our previous findings, osanetant impaired fear memory consolidation when given to mice with the control LV-GFP (post hoc, *p % 0.05 versus LV-GFP-Veh; Figure 5H , right). Additionally, the enhanced fear memory consolidation caused by CeA-Tac2 overexpression was reversed by osanetant (post hoc, **p % 0.01 versus LV-Tac2-Osa and LV-GFP-Osa; Figure 5H , right). See Figure S5 for a graphical representation of the Tac2-LV overexpression.
Silencing of Tac2-Expressing Cells and Emotional Learning
To further understand the role of the Tac2 gene, we temporarily silenced the activity of neurons expressing this gene in the CeA during fear learning using designer receptors exclusively activated by designer drugs (DREADD) technology. The B6.129-Tac2tm1.1(cre)Qima/J (Tac2-Cre) (Mar et al., 2012) mice were infected with a DREADD Gi-coupled receptor via the pAAV-hSyn double-floxed hM4D-mCherry virus (hM4Di-mCherry AAV) (Figure 6A ). This elicited specific expression of the mCherry reporter in Tac2 cells within the CeA, but not any other area of the brain, suggesting the insertion of the DREADD receptor on the plasma membrane (Figures 6B and 6C ; Krashes et al., 2011) . Fourteen days later, clozapine-N-oxide (CNO), which binds to the inserted receptor but otherwise is pharmacologically inert, was given systemically 30 min before FC in both groups, Tac2-Cre-/ hM4Di-mCherry and Tac2-Cre+/hM4Di-mCherry. CNO had no effect on fear acquisition as shown by equivalent amount of freezing in both groups ( Figure 6D ). However, when animals were tested for fear expression, 24 hr later in the absence of CNO, the Tac2-Cre+/hM4Di-mCherry mice presented less freezing, suggesting impaired fear memory consolidation (Student's t test, t = 3.257, *p % 0.05 Tac2-Cre-/hM4Di-mCherry versus Tac2-Cre+/hM4Di-mCherry; Figure 6D ). This demonstrates that the animals expressing Tac2-Cre+/hM4Di-mCherry and inducible Gi to temporally silence the activity of Tac2-expressing neurons exhibit significantly less fear consolidation when tested for fear learning. Mice were then retrained with a different CS and a different context in the same FC apparatus, as in previous experiments but without dosing CNO. Tac2-Cre-/hM4Di-mCherry and Tac2-Cre+/hM4Di-mCherry mice showed similar amount of freezing in the FC and fear expression test ( Figure 6E ). This suggests that when Tac2-expressing neurons are not silenced, there is normal fear memory consolidation in both Tac2-Cre-/hM4Di-mCherry and Tac2-Cre+/hM4Di-mCherry groups. Moreover, when given CNO, these two groups presented equivalent levels of anxiety-like behavior and pain sensitivity ( Figure 6F and Figure S6 ).
DISCUSSION
Previous reports have shown that Nk3R is associated with memory processes in hippocampus-dependent tasks in rodents (de Souza Silva et al., 2013; Siuciak et al., 2007; Zlomuzica et al., 2008) . Here, we provide evidence that Tac2-NkB-Nk3R signaling within the CeA is required for the modulation of fear memory consolidation. Other studies have shown that the CeA is required for the acquisition, consolidation, and expression of fear memories (Wilensky et al., 2006) . Here we show mechanisms that may also be involved in those processes within the CeA. To the best of our knowledge, this is the first evidence that a neuronal population specifically highly expressed in the CeM, Tac2 and its product NkB peptide, are required for the modulation of fear memory consolidation affecting neither unconditioned fear nor anxiety-like behavior. All that is known about NkB release is from in vitro experiments, where it is suggested that NkB release is potassium evoked and calcium dependent, fulfilling the criterion of a neurotransmitter or a neuromodulator (Lindefors et al., 1985) . More studies about this topic would be desirable to further understand the mechanisms of the Tac2/ NkB/Nk3R pathway.
Our findings also suggest that CeA-Tac2 lentiviral overexpression enhances fear memory consolidation but Nk3R antagonism prevents it. This shows that Nk3R antagonism within the CeA is able to normalize dysregulated functioning induced by the Tac2 gene. We believe that it is possible that osanetant given systemically or intracranially within the CeA may be acting in the Nk3R in all areas of CeA and not only in the CeM (Smith and Flynn, 2000; Yip and Chahl, 1997) . This impairment of fear memory consolidation by Nk3R antagonism is consistent with previous reports where Nk3R activation with senktide in the hippocampus and cortex leads to enhanced postsynaptic depolarization and long-term potentiation (LTP) in slice physiology studies, and this effect was blocked by NK3R antagonism (Gallopin et al., 2006; Rekling, 2004) . However, specific electrophysiological experiments in the amygdala should be performed in the future to study whether activation or blockade of the Nk3R in this structure is involved in LTP or other types of activity-dependent plasticity.
In agreement with these prior findings, specific and temporal pharmacogenetic silencing of Tac2-expressing neurons in the CeA with DREADDs leads to impaired fear memory consolidation. Of note, no effects in fear acquisition, pain sensitivity, or anxiety-like behavior were detected when overexpressing Tac2, inhibiting Tac2-expressing neurons, or with the Nk3R antagonist, which is consistent with previous findings suggesting that the Tac2-NkB-Nk3R pathway is not directly involved in these processes, although it may modulate them (Ebner et al., 2009; Mar et al., 2012; Siuciak et al., 2007) . Interestingly, in our fear paradigm, the Tac2 gene within the amygdala is involved in auditory (CS+US paired) but not stress or contextual memories (US only). However, this does not preclude the hypothesis that different fear paradigms might reveal a role of Tac2 in the amygdala in contextual fear conditioning.
Thus, we believe that enhanced Tac2 gene expression in our fear models enhanced NkB production in the amygdala, binding to Nk3R and promoting fear memory consolidation. This upregulation of Tac2 mRNA levels primarily within the CeM suggests several possible nonmutually exclusive scenarios. The first is that the Tac2 gene synthesizes NkB in the CeM amygdala, acting on local Nk3R within the CeM specifically. The second is that Tac2 mRNA and/or NkB are transported from the CeM to other nuclei within the amygdala such as CeL, CeC, or BLA, where they bind to the Nk3R. Our data also suggest that amygdala cell culture with osanetant increases Nk3R mRNA levels. The most likely interpretation is that osanetant antagonizes amygdala Nk3R and due to its decreased availability, Nk3R mRNA is increased to synthesize more Nk3R in a compensatory manner. The current data provide intriguing support for a specific role of Tac2 gene, via NkB activation of Nk3R in fear consolidation within the CeA.
CeLon neurons essentially serve as disinhibitory cells for CeLoff neurons. Both CeLon and CeLoff neurons release GABA when activated. CeLon neurons send projections to CeLoff neurons, and, therefore, the increased firing of CeLon neurons during CS presentation results in inhibition of CeLoff neurons (normally inhibiting the CeM) and, thus, in disinhibition of CeM, promoting conditioned fear responses . Specifically, CeLoff neurons largely overlap with PKCd+ neurons (Haubensak et al., 2010) . Moreover, we also show that Tac2 gene is not colocalized with Enk in the CeM. Enk is colocalized with PKCd in the CeL (Haubensak et al., 2010) and specific CeA-Enk deletion decreases fear expression during FC without 
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Tac2 and Nk3 Receptor in Fear Memory Consolidation affecting fear memory consolidation (Poulin et al., 2013) . Thus, the Tac2-CeM neuronal population appears to be independent of, and complementary to, other previously described neuronal populations involved in FC. The GAD65 peptide, abundantly found at nerve terminals and synapses, plays a key role in GABA neurotransmission (Pinal and Tobin, 1998) . Additionally, CaMKII is a well-known marker for synaptic plasticity. Thus, the colocalization of Tac2 mRNA levels and GAD65 and CaMKIIa peptides in the CeM suggest that Tac2 gene may have a role in However, when mice were tested the day after for fear expression, without CNO, Tac2-Cre+/hM4Di-mCherry mice showed less conditioned fear. *p % 0.05 Tac2-Cre-/hM4Di-mCherry versus Tac2-Cre+/hM4Di-mCherry, n = 10-11 per group. (E) Tac2-Cre-/hM4Di-mCherry and Tac2-Cre+/ hM4Di-mCherry mice were retrained to a different acoustic tone (CS) without receiving CNO. Both groups equally acquired fear learning and showed similar levels of fear memory consolidation. (F) CNO given 30 min before the elevated plus maze showed no effect on Tac2-Cre-/hM4Di-mCherry or Tac2-Cre+/hM4Di-mCherry in anxiety-like behavior. See also Figure S6 . neurotransmission within the GAD65 and CaMKIIa-expressing neurons, in agreement with our data that suggest that this CeM population may be critically involved in fear memory consolidation.
Finally, one of the most interesting aspects of our data is the potential use of the Nk3R antagonist osanetant as a pharmacological agent to block fear memory consolidation shortly after exposure to a trauma. Additionally, we found that osanetant prevented the upregulation of the Adcyap1r1 gene, which encodes the PAC1 receptor. The PA-CAP-PAC1R pathway is involved in PTSD, fear conditioning, amygdala excitatory neurotransmission, and stress (Almli et al., 2013; Cho et al., 2012; Hashimoto et al., 2011; Ressler et al., 2011; Uddin et al., 2013) . All this could be relevant in PTSD prevention since it has previously been found that osanetant is safe in humans, although additional preclinical studies, such as those described herein, are needed first to establish the mechanisms involved. This gives our findings an exciting potential approach to translation to human patients. Although other molecular pathways have previously been associated with PTSD, we believe that there will be a number of different mechanisms identified that eventually will synergistically be used to target emotional memory modulation.
In summary, these studies provide understanding of the role of the Tac2 gene and the CeM in fear processing and provide approaches to intervention for fear-related disorders.
EXPERIMENTAL PROCEDURES
Procedures are described in detail in Supplemental Experimental Procedures.
Mice Amygdala cell culture experiments were performed with male wild-type (WT) C57BL/6J p21 mice. All other experiments were performed on adult WT C57BL/6J or B6.129-Tac2tm1.1(cre)Qima/J (Tac2-Cre) (Mar et al., 2012) from Jackson Laboratory (Stock 018938), male mice that were group-housed in a temperature-controlled vivarium, with ad libitum access to food and water. Animals were maintained on a 12 hr/12 hr light/dark cycle, with all behavioral procedures being performed during the light cycle. All procedures used were approved by the Institutional Animal Care and Use Committee of Emory University and in compliance with National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
Immobilization to Wooden Board Mice were exposed once for 2 hr to IMO, which was performed as previously described (Andero et al., 2011 (Andero et al., , 2013 .
mRNA Extraction and Microarray
Total mRNA was isolated and purified from the tissue with the RNeasy Mini Kit (catalog 74106, QIAGEN). Illumina MouseWG-6 v2 Expression BeadChip microarray (Illumina) was assayed for 45,281 transcripts as previously described (Andero et al., 2013) . FDR was calculated with SAM 4.01 using a 5% cutoff for the FDR rate. The heat maps were created with Genesis 1.4.0 (Sturn et al., 2002) . The pathway analysis was generated through the use of IPA (Ingenuity Systems, http://www.ingenuity.com). The microarray data are publicly available in the Gene Expression Omnibus database under accession number GSE57465.
Behavioral Experiments
Elevated plus-maze, open-field, cued-fear conditioning, and fear expression tests were performed as previously described (Andero et al., 2011 (Andero et al., , 2013 . The CS was 30 s 0.6 kHz tone and the US was 1 mA 500 ms electric footshocks. Retraining of mice was performed with a 12 kHz tone.
Complementary DNA Synthesis and qPCR Total mRNA was reverse transcribed with the RT 2 First Strand Kit (catalog 330401, QIAGEN). The primers used for the qPCR were TaqMan Tac2 Mm01160362_m1, ADCYAP1R1 Mm01326453_m1, and NK3R Mm00445346_m1 from Applied Biosystems. The qPCR was performed and analyzed as previously described (Andero et al., 2013) .
Radioactive In Situ Hybridization
Tissue was fixed in 4% paraformaldehyde, pretreated, and hybridized with 36SUTP-labeled cRNA riboprobes prepared from linearized constructs for antisense sequence of Tac2 (T7 RNA polymerase) as previously described (Rattiner et al., 2004) .
Fluorescent In Situ Hybridization cRNA riboprobes were prepared from linearized constructs for antisense sequences of Tac2, PKCd, and Enkephalin (T7 RNA polymerase) as previously described (Jasnow et al., 2013) . The Tac2 riboprobe was labeled with fluorescein and the PKCd and Enkephalin with digoxigenin. Signals were amplified with the TSA Plus Fluorescein Fluorescence System or TSA Plus Cy5 Fluorescence System (PerkinElmer) following each series of primary antibodies. Sections were then stained with DAPI (1:1,000), washed, and coverslipped with Mowiol mounting medium (Jasnow et al., 2013) .
Amygdala Cell Culture Amygdala primary cell culture was performed as previously described (Mou et al., 2011) .
Immunohistochemistry
Pep2/ProNkB, IS-39 ab (1:500) was the antibody used to detect NkB. The procedure was followed as previously described (Kalló et al., 2012) . The procedure for detecting Gad65 (AB5082, Chemicon, 1:500) and CaMkIIa (Cell Signaling Solutions, 1:250) was similar as previously described (Jasnow et al., 2013) after performing the Tac2 FISH. After the ISH and IHC sections were stained with DAPI (1:1,000), they were washed and coverslipped with Mowiol mounting medium.
Immunocytochemistry
Immunocytochemistry was performed as previously described (Mou et al., 2011) . The antibody used was Pep2/ProNkB IHC (IS-39 ab, 1:500) (Kalló et al., 2012) and DAPI or NeuN (1:1,000).
ELISA
The mouse Neurokinin B ELISA kit was purchased from Mybiosource (Catalogue MBS744693). The inter-assay coefficient of variation is 7.5%-8.6%, the intra-assay coefficient of variation is 8.2%-9.5% and the spike recovery is 95%-103%. Procedure was followed as indicated by the manufacturer.
Production of Recombinant Viral Vectors
Mixture for transfection was 250 ug of FUGW or FUW-Tac2 + 187.5 ug of pCMVdelta 8.9 + 75 ug of pV-SVG + 12 ml of ddH2O + 12.5 ml of 0.5M Ca2Cl + 25 ml of 23 HeBS to total volume 50 ml; this solution was vortexed a few seconds and incubated for 20 min at room temperature. Procedure was followed as previously described (Huang et al., 2013) . The pAAV-hSyndouble floxed hM4D-mCherry (hM4Di-mCherry AAV) was purchased from UNC Gene Therapy Center.
Surgery and Injection of Virus
Mice were anesthetized and placed in a stereotaxic frame. CeA coordinates were as follows: anteroposterior, À1.34 mm; dorsoventral, À4.4 mm; mediolateral, À2.4 mm relative to bregma. For the LV-Tac2 experiments, the animals received bilateral intra-CeA amygdala injections of lentiviral vectors expressing Tac2-FUW or FUGW (GFP) in 1% BSA in PBS, 0.5 ml of virus/side. We injected 1 ml of virus/side of the pAAV-hSyn-double floxed hM4D-mCherry (hM4Di-mCherry AAV) in the CeA of Tac2-Cre-and Tac2-Cre+ mice. For all experiments, the rate of injection was 0.1 ml/min and the needle was left in place for 10 min after injection and the skin was closed using a 6-0 Vicryl suture.
Drug Administration
The Nk3R antagonist osanetant (Axon Medchem, Axon 1533) was dissolved in physiological saline and 0.1% Tween 20, which was also the vehicle. Intraperitoneal (i.p.) dose was 5 mg/kg for systemic administration and 0.5 ml with 625 ng dose per side for the intra-CeA studies. Cannulation of the mice was performed as previously described (Andero et al., 2013) . Clozapine-N-oxide (CNO, Sigma Aldrich C0832) was given i.p. at 1 mg/kg (Krashes et al., 2011) .
Statistics
Statistics were performed with IBM SPSS Statistics 19.0. Detection of outliers was performed and, when necessary, removed from analyses. ANOVA followed by post hoc analyses were appropriate, repeated-measures ANOVA, or Student's t test (two-tailed) for independent samples was tested.
The results are presented as means ± or + SEM, and statistical significance was set at p % 0.05.
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